According to the sources provided, Vascepa is a prescription medication that contains the active ingredient icosapent ethyl. It is primarily used to lower triglyceride levels in adults with severe hypertriglyceridemia.

The first source, DrugPatentWatch, provides information on the patent status of Vascepa. It indicates that the drug is currently under patent protection until 2030. This suggests that generic versions of Vascepa may not be available until after the patent expires.

The second source, Drugs.com, explains the difference between Vascepa and another medication called Lovaza. Both medications are used to lower triglyceride levels, but they contain different active ingredients. Lovaza contains omega-3 fatty acids, while Vascepa contains icosapent ethyl. The article states that Vascepa has been shown to be more effective than Lovaza in reducing triglyceride levels.

The third source, Healthline, provides general information about Vascepa. It mentions that Vascepa is a purified form of omega-3 fatty acid and is derived from fish oil. It also states that Vascepa has been shown to significantly reduce triglyceride levels in clinical studies.

Based on the information from these sources, it can be concluded that Vascepa is a prescription medication that is currently under patent protection. It contains the active ingredient icosapent ethyl and is primarily used to lower triglyceride levels in adults with severe hypertriglyceridemia. Vascepa has been shown to be more effective than Lovaza in reducing triglyceride levels. However, it is important to consult with a healthcare professional for personalized medical advice and to discuss the potential benefits and risks of Vascepa versus generic alternatives.

Sources:
[1] DrugPatentWatch: https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] Drugs.com: https://www.drugs.com/medical-answers/lovaza-vascepa-difference-between-3553025/
[3] Healthline: https://www.healthline.com/health/drugs/vascepa